111 related articles for article (PubMed ID: 6222712)
1. Effects of prostacyclin infusion on platelet activation and postoperative blood loss in coronary bypass.
Aren C; Feddersen K; Rådegran K
Ann Thorac Surg; 1983 Jul; 36(1):49-54. PubMed ID: 6222712
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostacyclin infusion on platelets and hemodynamics in coronary bypass surgery.
Arén C; Feddersen K; Rådegran K
Thorac Cardiovasc Surg; 1984 Apr; 32(2):81-4. PubMed ID: 6204413
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
Rådegran K; Arén C; Teger-Nilsson AC
J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
[TBL] [Abstract][Full Text] [Related]
4. Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin.
Plachetka JR; Salomon NW; Larson DF; Copeland JG
Ann Thorac Surg; 1980 Jul; 30(1):58-63. PubMed ID: 6994666
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
[TBL] [Abstract][Full Text] [Related]
6. A double blind study of prostacyclin in cardiopulmonary bypass surgery.
Walker ID; Davidson JF; Faichney A; Wheatley DJ; Davidson KG
Br J Haematol; 1981 Nov; 49(3):415-23. PubMed ID: 6457624
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
[TBL] [Abstract][Full Text] [Related]
8. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.
Malpass TW; Amory DW; Harker LA; Ivey TD; Williams DB
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):550-5. PubMed ID: 6231433
[TBL] [Abstract][Full Text] [Related]
9. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization.
DiSesa VJ; Huval W; Lelcuk S; Jonas R; Maddi R; Lee-Son S; Shemin RJ; Collins JJ; Hechtman HB; Cohn LH
Ann Thorac Surg; 1984 Nov; 38(5):514-9. PubMed ID: 6388516
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin and iloprost do not affect action of standard dose heparin on haemostatic function during haemodialysis.
Dibble JB; Kalra PA; Orchard MA; Turney JH; Davies JA
Thromb Res; 1988 Feb; 49(4):385-92. PubMed ID: 2454514
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
12. Platelet proteins during and after prostacyclin therapy for lower limb ischaemia--suggestion of a rebound platelet activation.
Blättler W; Furrer K; Schriber K; Kofmehl R; Massini C
Vasa; 1981; 10(3):261-3. PubMed ID: 6169225
[No Abstract] [Full Text] [Related]
13. Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations.
Kappa JR; Horn MK; Fisher CA; Cottrell ED; Ellison N; Addonizio VP
J Thorac Cardiovasc Surg; 1987 Sep; 94(3):405-13. PubMed ID: 2442566
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostacyclin during cardiopulmonary bypass in man.
Rådegran K; Egberg N; Papaconstantinou C
Scand J Thorac Cardiovasc Surg; 1981; 15(3):263-8. PubMed ID: 6753137
[No Abstract] [Full Text] [Related]
15. Prostacyclin administration during cardiopulmonary bypass in man.
Longmore DB; Bennett JG; Hoyle PM; Smith MA; Gregory A; Osivand T; Jones WA
Lancet; 1981 Apr; 1(8224):800-4. PubMed ID: 6111672
[TBL] [Abstract][Full Text] [Related]
16. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
17. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).
Addonizio VP; Fisher CA; Kappa JR; Ellison N
Surgery; 1987 Nov; 102(5):796-807. PubMed ID: 2445042
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of prostacyclin infusion given before and during cardiopulmonary bypass to assess the first pass effect of the circuit on platelet number and function.
Jestice HK; Humphreys JE; English TA; Hoggarth CE; Wells FC
Eur J Cardiothorac Surg; 1990; 4(1):40-4. PubMed ID: 2106334
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostacyclin infusion on renal function during cardiopulmonary bypass.
Feddersen K; Arén C; Granérus G; Jagenburg R; Rådegran K
Ann Thorac Surg; 1985 Jul; 40(1):16-9. PubMed ID: 3925905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]